
Sign up to save your podcasts
Or
This is the second part of our series reconnecting with Fierce 15 winners from 2019, the first year Fierce Healthcare published the list of 15 private companies engaged in pioneering work
This week on "Podnosis," we catch up with the leaders of Elemeno Health and Digital Diagnostics, both recognized as Fierce 15 winners in 2019.
First up, Fierce’s Anastassia Gliadkovskaya chats with Arup Roy-Burman, M.D., the founder and chief medical officer at Elemeno Health. Roy-Burman reflects on Elemeno’s evolving mission to democratize information and its entry into new markets, accelerated by the COVID-19 pandemic.
Next, Fierce’s Noah Tong catches us up with Digital Diagnostics. The Iowa-based company rose to prominence because of its AI system that enabled a specialist diagnosis for diabetic retinopathy in a primary care setting. Noah interviews CEO John Bertrand about the company’s global expansion, its approach toward value-based care and the future of AI.
To learn more about the topics in this episode:
Digital Diagnostics dials up $75M funding for diabetic retinopathy AI
Baxter taps Digital Diagnostics' diabetic retinopathy AI for its Welch Allyn eye scanners
Microsoft, Wolters Kluwer collaborate on 'big picture insights' analytics offering for hospitals
Privia Health joins forces with AI startup Navina for point-of-care clinical insights
See omnystudio.com/listener for privacy information.
4.5
22 ratings
This is the second part of our series reconnecting with Fierce 15 winners from 2019, the first year Fierce Healthcare published the list of 15 private companies engaged in pioneering work
This week on "Podnosis," we catch up with the leaders of Elemeno Health and Digital Diagnostics, both recognized as Fierce 15 winners in 2019.
First up, Fierce’s Anastassia Gliadkovskaya chats with Arup Roy-Burman, M.D., the founder and chief medical officer at Elemeno Health. Roy-Burman reflects on Elemeno’s evolving mission to democratize information and its entry into new markets, accelerated by the COVID-19 pandemic.
Next, Fierce’s Noah Tong catches us up with Digital Diagnostics. The Iowa-based company rose to prominence because of its AI system that enabled a specialist diagnosis for diabetic retinopathy in a primary care setting. Noah interviews CEO John Bertrand about the company’s global expansion, its approach toward value-based care and the future of AI.
To learn more about the topics in this episode:
Digital Diagnostics dials up $75M funding for diabetic retinopathy AI
Baxter taps Digital Diagnostics' diabetic retinopathy AI for its Welch Allyn eye scanners
Microsoft, Wolters Kluwer collaborate on 'big picture insights' analytics offering for hospitals
Privia Health joins forces with AI startup Navina for point-of-care clinical insights
See omnystudio.com/listener for privacy information.
4,320 Listeners
25,715 Listeners
8,968 Listeners
86,172 Listeners
111,083 Listeners
485 Listeners
751 Listeners
1,984 Listeners
5,920 Listeners
386 Listeners
5,410 Listeners
146 Listeners
10,294 Listeners
963 Listeners
1,030 Listeners